《本地樓市》屋宇署2月批出11份建築圖則及8份入夥紙
屋宇署公佈,2月共批出11份建築圖則,其中港島2份、九龍5份及新界4份。當中包括8項住宅及商住發展、1項商業發展,以及2項社區服務發展。
獲準動工的建築工程項目有6個,這些工程完成後將提供可作住宅用途的建築樓面面積共3,839平方米,涉及單位70個,非住宅用途的建築樓面面積達4,712平方米。另外,該署亦接獲2個建築項目的上蓋工程動工通知。
屋宇署同時發出8份入夥紙,包括港島2份、九龍4份及新界2份。其中住宅用途的建築樓面面積有19.89萬平方米,共2,910個單位;而非住宅用途的建築樓面面積則爲14.65萬平方米。
2月份新落成樓宇的報價總值約爲149億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.